Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:
“Resistance to BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma: Biology, Clinical Patterns, and Strategies to Overcome Treatment Failure”
Title: Resistance to BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma: Biology, Clinical Patterns, and Strategies to Overcome Treatment Failure
Authors: Mohammad Ahsen Soomro, Mohamed Ahmed, Al Ola Abdallah, Nausheen Ahmed, Jeries Kort
Other articles featuring Al-Ola Abdallah on OncoDaily.
